Clinical Trial Update: Assessment of Suppression of Cutaneous Allergic Responses and Pruritus by Topical Doxycycline [Phase 2]

View source ↗

Summary

Phase 2 trial assessing suppression of cutaneous allergic responses and pruritus with topical doxycycline for hives.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• topical doxycycline (doxycycline)

Snippet

Sponsor: State University of New York - Downstate Medical Center | Conditions: Hives | Phase 2 | Status: UNKNOWN